Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation

Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):52-4. doi: 10.1007/s10096-005-0065-z.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Infective Agents
  • Antifungal Agents / therapeutic use*
  • Bone Marrow Transplantation / methods
  • Caspofungin
  • Contraindications
  • Echinocandins
  • Humans
  • Leukemia, Lymphoid / complications*
  • Leukemia, Lymphoid / therapy
  • Lipopeptides
  • Male
  • Middle Aged
  • Peptides, Cyclic / therapeutic use*
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / diagnostic imaging
  • Pneumonia, Pneumocystis / drug therapy*
  • Positron-Emission Tomography / methods
  • Tomography, X-Ray Computed / methods
  • Transplantation Conditioning / methods
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Anti-Infective Agents
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Caspofungin